The FDA has approved only one CBD product.
It is a prescription drug product that treats seizures associated with Lennox Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC).
The product usage is intended for humans one year or older.
Yes – it’s a first step in the right direction. Let’s hope the FDA have others in the pipeline.